DEUTSCHE BANK AG\ - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 46 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$35,000
-55.7%
17,102
-10.1%
0.00%–
Q4 2021$79,000
-53.0%
19,022
+5.3%
0.00%–
Q3 2021$168,000
-38.5%
18,058
+19.4%
0.00%–
Q2 2021$273,000–15,128–0.00%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders